MedTrace Logo

Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants

NCT04929743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-02-25

No results posted yet for this study

Summary

The main aim of this clinical trial is to analyze the survival rate of short-length implants (\<4.5 mm) in partial edentulism subjects. 6.5 mm length implants will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.

Conditions

  • Partial-edentulism

Interventions

DEVICE

BTI Implant

Placement of dental implants of 5.5 vs \>6.5 mm length

Sponsors & Collaborators

  • Fundación Eduardo Anitua

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-11
Primary Completion
2024-11-27
Completion
2024-11-27
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929743 on ClinicalTrials.gov